Better than expected!
Good news comes from the world's first inactivated COVID-19 vaccine
◎ Science and Technology Daily reporter Qu Jian
According to the latest news from Sinopharm Sinopharm, the world’s first inactivated COVID-19 vaccine developed by Sinopharm’s Phase III clinical trials in multiple countries is now nearing completion, and all trial data are better than expected; Sinopharm Sinobio will strictly follow relevant procedures Promoting vaccine research and development, "will not omit any link to ensure that the safest vaccine is provided."
According to Sinopharm Sino Biotech, the Phase III clinical trial of its new crown inactivated vaccine is progressing smoothly in the UAE, Bahrain, Egypt, Jordan, Morocco, Peru, Argentina and other countries, and has entered the final sprint stage. More than 50,000 volunteers have been inoculated. The population covers 125 nationalities.
China's new biological new crown vaccine phase III clinical trial site in Abu Dhabi
The Phase III clinical trials of the new crown vaccine carried out by Sinopharm Sino Biotech in various countries have been strongly supported and fully affirmed by the local government. Many politicians strongly supported and took the lead in vaccination, and expressed their opinions on the safety, effectiveness and phase III clinical trials of China's new crown vaccine. Experiment with confidence.
Including more than ten senior UAE officials including the Vice President and Prime Minister of the UAE, Al Maktoum, the Chief of Dubai, the Crown Prince Salman bin Hamad Al Khalifa of Bahrain, the Chairman of the Supreme Health Council, and the Minister of Health. A large number of senior government officials, Egyptian Minister of Health and Population Harley, etc.
During the phase III clinical trial, the UAE and Bahrain have approved the emergency use of the vaccine on September 15 and November 3 respectively.
According to reports, emergency vaccinations include front-line medical staff, teachers, police and customs personnel.
On November 6, the 3rd Hongqiao International Health Technology Innovation Forum was held in the 3rd CIIE Pavilion. At the forum, Liu Jingzhen, Chairman of Sinopharm Group, said when talking about the topic of new crown vaccine, there are currently hundreds of thousands. People were vaccinated urgently with two new inactivated vaccines under the Sinopharm Group. There was no serious adverse reaction. The number of people who left the country after vaccination reached 56,000, and none of them have been infected.
Liu Jingzhen said that he was injected with the new crown vaccine in March of this year, and that he "is still alive and well without any side effects."
Whether it is from scientific research test data or use around the world, the effectiveness of the new crown vaccine has been proved.
Source: Science and Technology Daily, part of the content is integrated from China Youth Daily